1st Annual European Healthcare Impact Summit

Incorporating 13th HealthTech Investment Forum & 8th HealthTech Innovation Days

6th of October 2026|MÖVENPICK HOTEL BASEL | SWITZERLAND

Attendees:

3B Future Health Fund

3i Group plc

abcDNA GmbH

Abivax SA

Accequa

AdBio Partners

Afendis Capital Management

AltamarCAM Partners

Alternative Assets Finance

Altrovia

Ampleia

AMR Action Fund GP GmbH

AP-HP (Greater Paris University Hospitals)

ARCHIMED

Argobio Studio

AstraZeneca

Atlas Capital Ventures LLC

Awen GmbH

Basel Area Business & Innovation

Basel Area Business & Innovation - DayOne

Bayer Pakistan Limited

Bergaud & Partners

BERNINA BioInvest Ltd.

Bio Med Gene Ventures

BioMedPartners AG

BIOSTART Consulting GmbH

Bioxodes SA

BlackRock

Blackstone Group

Bloomberg Intelligence

Boehringer Ingelheim International GmbH

BOHE Angel Fund

Bpifrance

Brainomix Limited

Brenus Pharma

Breslin AG

Brightlands Venture Partners

Capital Grand Est

CB Therapeutics

CDR-Life, Inc.

CheckBrain Therapeutics

Claris Ventures

Cohesion Bureau

Convergence Partners

Coulter Partners

Covington & Burling LLP

DeBere Partners Limited

Digital Networks PLC

docdok.health Ltd.

Earlybird Health Management GmbH & Co. KG

Ebenbuild GmbH

European Braintech Fund

European Investment Bank

European Investment Fund

F. Hoffmann-La Roche AG

FastVentures B.V.

FluoSphera SA

Fontaine Capital

Forta Bio, Inc.

Forty51 Ventures AG

Forvis Mazars

FreeMind Group

Fresenius Ventures

Generation Fund Life Sciences Fund I

Genevant Sciences GmbH

Gilde Healthcare Partners BV

Gimv

Global Close Alliances Ltd.

Goetzpartners Securities

GOLDTRACK Ventures GmbH

GSK

Gustave Roussy

hema.to GmbH

High-Tech Gründerfonds Management GmbH

i&i Biotech Fund I SCSp

ICF Consult Switzerland

iniuva GmbH

Innovestor Life Science Ltd.

Innunity Therapeutics

INOGROUP GmbH

Insilico Medicine

Invariant Capital AG

IPF Partners

Italian Angels for Growth (IAG)

Kaleida Capital Management LLC

Karista

KG Capital Management LLC.

Kinled Holding Limited

Landmark BioVentures AG

Laverock Therapeutics Ltd.

LifeCare Partners GmbH

Lifespan Vision Ventures LLC

LIMAA Technologies GmbH

Lynx Financial Hong Kong Ltd.

Medical Valley EMN e.V.

MEDiSTRAVA

Merck KGaA

Mérieux Equity Partners

Mission BioCapital

Modi Ventures

MONCYTE Health

MTIP AG

Nanoflex Robotics AG

NGScopes GmbH

Nitinotes Ltd.

Nœtica Pharma

NovaPump GmbH

Novartis AG

NS Pharma, Inc.

Nucleo Technologies, Inc.

NxR Biotechnologies GmbH

OKG Capital LP

Oncode Accelerator

Oxford Science Enterprises plc

Panakès Partners SGR SpA

Peppermint VenturePartners GmbH

Peregrine Ventures

PreciPoint GmbH

PSCC

Rahim Invest SÀRL

RDS SAS

Rhea BioVentures

RV Invest GmbH

SC MEDICA

Schwarz Financial Communication

SEQENS

Seventure Partners

Skaaltec AG

SPARK Finland

Stifel

Strategic Transactions Advisory AG

Sunstone Life Science Ventures

Swiss Biotech Association

Syntex Limited

TargImmune Therapeutics AG

Terra Quantum AG

Therakles Pharmaceuticals AG

TheraVenture GmbH

TVM Capital Life Science

UCB Ventures

University of Zurich

USI Startup Centre

UZH Life Sciences Fund, AG

VALANX Biotech GmbH

Venture Valuation VV AG

Verge HealthTech Fund

Versant Ventures

Vi Partners AG

Viopas Venture Consulting GmbH

VUS Genetics

Wellington Partners

WG Partners LLP

WhiteLab Genomics

XGEN Venture SGR S.p.A.

YAYA Capital

Zühlke Ventures AG

Last updated: September 16, 2026